Legislation related to neurotrauma drug approval and neurotrauma medical research.
2025 · 3rd Quarter (July 1 - Sep 30)
NERVGEN PHARMA CORP.
Filed by CORNERSTONE GOVERNMENT AFFAIRS, INC..
Open official filingSource-reported fields
Filing overview
- Type
- Registration - Amendment
- Posted
- Sep 22, 2025
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- CORNERSTONE GOVERNMENT AFFAIRS, INC.
- Client
- NERVGEN PHARMA CORP.
- Filing UUID
- 957cf25c-d0de-49e6-8ed6-c2cc4da35e99
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Legislation related to neurotrauma drug approval and neurotrauma medical research.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.